GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
Clinical trial NCT03576612 · COMPLETED
Trial details
- NCT number
- NCT03576612
- Sponsor
- Candel Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2023-06-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.